Molecular docking and 100 ns molecular dynamics simulations revealed that pheophorbide a forms a highly stable complex with GLUT1, consistent hydrogen bonding, minimal structural fluctuations and sustained structural compactness, highlighting its strong binding affinity and potential as a GLUT1-targeted therapeutic agent in diabetes [81]. This evidence concerns the gene SLC2A1 and diabetes mellitus.